This is where you are wrong - every patient treated with an anthracycline suffers heart damage. Some suffer more than others, but none escape.
It would be worth asking your favourite company what their assumptions around pricing are and how they were determined. We have shared our primary market research on this question with our investors as we want them to make informed and rational investment decisions.
This is where you are wrong - every patient treated with an...
-
- There are more pages in this discussion • 487 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
0.000(0.00%) |
Mkt cap ! $289.7M | |||
| Open | High | Low | Value | Volume |
| $1.70 | $1.70 | $1.66 | $85.03K | 50.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 21581 | $1.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.70 | 4979 | 4 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |